Bivin & Associates, Inc. Dexcom Inc Transaction History
Bivin & Associates, Inc.
- $93.1 Million
- Q2 2022
A detailed history of Bivin & Associates, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Bivin & Associates, Inc. holds 360 shares of DXCM stock, worth $28,886. This represents 0.03% of its overall portfolio holdings.
Number of Shares
360
Previous 90
300.0%
Holding current value
$28,886
Previous $46,000
41.3%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding DXCM
# of Institutions
1,014Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.81 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.77 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.44 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.34 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.21 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...